← 產業報告目錄
Solid Organ Transplantation (SOT) Market Size, Share & Trends Analysis Report By Organ (Renal, Liver, Heart, Lung, Pancreatic, Intestinal Transplantation, Others), By Treatment (Immunosuppressive, Monoclonal Antibodies, Others), By End User (Hospitals, Specialty Centers, Homecare, Others), By Region, And By Segment Forecasts, 2024-2031
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-02-25頁數 175報告編號 INSIGHTACE-5615ff528c
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
The global Solid Organ Transplantation (SOT) Market is set to surge at a compound annual growth rate of 6.91% throughout the 2024–2031 forecast period.
Solid Organ Transplantation (SOT) covers The solid organ transplantation (SOT) market encompasses services. Rapid advancements and evolving end-user preferences are reshaping how healthcare entities approach this space.
Market momentum is bolstered by growing requirement advanced solutions, favorable regulatory frameworks, and robust investment in research and development across major economies.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, bolstered by rapid industrialization and expanding end-user bases.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
This comprehensive research study delivers granular insights into market sizing, trend analysis, competitive benchmarking, and forward-looking projections to support strategic decision-making for industry participants and investors.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Solid Organ Transplantation (SOT) Market Snapshot
Chapter 4. Global Solid Organ Transplantation (SOT) Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Organ Estimates & Trend Analysis
5.1. by Organ & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Organ:
5.2.1. Renal
5.2.2. Liver
5.2.3. Heart
5.2.4. Lung
5.2.5. Pancreatic
5.2.6. Intestinal Transplantation
5.2.7. Others
Chapter 6. Market Segmentation 2: by Treatment Estimates & Trend Analysis
6.1. by Treatment & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Treatment:
6.2.1. Immunosuppressive
6.2.2. Monoclonal Antibodies
6.2.3. Others
Chapter 7. Market Segmentation 3: by End-Users Estimates & Trend Analysis
7.1. by End-Users & Market Share, 2019 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by End-Users:
7.2.1. Hospitals
7.2.2. Homecare
7.2.3. Specialty Centers
7.2.4. Others
Chapter 8. Solid Organ Transplantation (SOT) Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Solid Organ Transplantation (SOT) Market Revenue (US$ Million) Estimates and Forecasts by Organ, 2024-2031
8.1.2. North America Solid Organ Transplantation (SOT) Market Revenue (US$ Million) Estimates and Forecasts by Treatment, 2024-2031
8.1.3. North America Solid Organ Transplantation (SOT) Market Revenue (US$ Million) Estimates and Forecasts by End-Users, 2024-2031
8.1.4. North America Solid Organ Transplantation (SOT) Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.2. Europe
8.2.1. Europe Solid Organ Transplantation (SOT) Market Revenue (US$ Million) Estimates and Forecasts by Organ, 2024-2031
8.2.2. Europe Solid Organ Transplantation (SOT) Market Revenue (US$ Million) Estimates and Forecasts by Treatment, 2024-2031
8.2.3. Europe Solid Organ Transplantation (SOT) Market Revenue (US$ Million) Estimates and Forecasts by End-Users, 2024-2031
8.2.4. Europe Solid Organ Transplantation (SOT) Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.3. Asia Pacific
8.3.1. Asia Pacific Solid Organ Transplantation (SOT) Market Revenue (US$ Million) Estimates and Forecasts by Organ, 2024-2031
8.3.2. Asia Pacific Solid Organ Transplantation (SOT) Market Revenue (US$ Million) Estimates and Forecasts by Treatment, 2024-2031
8.3.3. Asia-Pacific Solid Organ Transplantation (SOT) Market Revenue (US$ Million) Estimates and Forecasts by End-Users, 2024-2031
8.3.4. Asia Pacific Solid Organ Transplantation (SOT) Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.4. Latin America
8.4.1. Latin America Solid Organ Transplantation (SOT) Market Revenue (US$ Million) Estimates and Forecasts by Organ, 2024-2031
8.4.2. Latin America Solid Organ Transplantation (SOT) Market Revenue (US$ Million) Estimates and Forecasts by Treatment, 2024-2031
8.4.3. Latin America Solid Organ Transplantation (SOT) Market Revenue (US$ Million) Estimates and Forecasts by End-Users, 2024-2031
8.4.4. Latin America Solid Organ Transplantation (SOT) Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.5. Middle East & Africa
8.5.1. Middle East & Africa Solid Organ Transplantation (SOT) Market Revenue (US$ Million) Estimates and Forecasts by Organ, 2024-2031
8.5.2. Middle East & Africa Solid Organ Transplantation (SOT) Market Revenue (US$ Million) Estimates and Forecasts by Treatment, 2024-2031
8.5.3. Middle East & Africa Solid Organ Transplantation (SOT) Market Revenue (US$ Million) Estimates and Forecasts by End-Users, 2024-2031
8.5.4. Middle East & Africa Solid Organ Transplantation (SOT) Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Teva Pharmaceutical Industries Ltd
9.2.2. Mylan N.V
9.2.3. Johnsons & Johnsons Services Inc
9.2.4. F. Hoffman-La Roche Ltd.
9.2.5. Lilly
9.2.6. Merck & Co., Inc.
9.2.7. Aurobindo Pharma
9.2.8. Bristol-Myers Squibb Company
9.2.9. GSK plc
9.2.10. Ascendis Pharma A/S
9.2.11. LEO Pharma A/S
9.2.12. Genentech, Inc
9.2.13. CAREDX
9.2.14. Glycorex Transplantation AB
9.2.15. DaVita Inc.
9.2.16. Celltrion Inc
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們